The Sweet Side of Fungal Infections: Structural Glycan Diversity and Its Importance for Pathogenic Adaptation.
Israel Diniz-LimaLeonardo Marques da FonsecaJhenifer Santos Dos ReisMarcos André Rodrigues da Costa SantosKelli Monteiro da CostaCarlos Antonio do Nascimento SantosPedro Marçal BarcelosKamila Guimarães-PintoAlessandra Almeida FilardyMarco Edilson Freire de LimaDebora Decote-RicardoAlexandre MorrotCelio Geraldo Freire-de-LimaLeonardo Freire-de-LimaPublished in: Medicines (Basel, Switzerland) (2022)
Fungal infections are the most common secondary infections in debilitated individuals in a state of chronic disease or immunosuppression. Despite this, most fungal infections are neglected, mainly due to the lower frequency of their more severe clinical forms in immunocompetent individuals with a healthy background. However, over the past few years, several cases of severe fungal infections in healthy individuals have provoked a change in the epidemiological dynamics of fungal infections around the world, both due to recurrent outbreaks in previously infrequent regions and the greater emergence of more pathogenic fungal variants affecting healthy individuals, such as in the Cryptococcus genus. Therefore, before the arrival of a scenario of prevalent severe fungal infections, it is necessary to assess more carefully what are the real reasons for the increased incidence of fungal infection globally. What are the factors that are currently contributing to this new possible epidemiological dynamic? Could these be of a structural nature? Herein, we propose a discussion based on the importance of the virulence factors of glycoconjugate composition in the adaptation of pathogenic fungal species into the current scenario of increasing severity of these infections.